[TOP STORY] Compounded weight-loss drugs raise serious patient safety concerns

Loading player...
‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr.
15 May 8AM English South Africa Business News · Politics

Other recent episodes